The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Combined Akt and MEK pathway blockade in pre-clinical models of enzalutamide-resistant prostate cancer.

Paul  Toren

Research Funding - Innocrin Pharma (Inst)

Soojin  Kim

No Relationships to Disclose

Ladan  Fazli

No Relationships to Disclose

Barry  Davies

Employment - AstraZeneca

Martin  Gleave

Employment - OncoGenex

Stock and Other Ownership Interests  - OncoGenex

Honoraria - Janssen, Astellas

Consulting or Advisory Role - Amgen; OncoGenex, Janssen, Astellas, AstraZeneca, Bayer

Speakers' Bureau - Janssen, Atellas

Research Funding - Janssen, Astellas

Travel, Accommodations, Expenses - Amgen

Amina  Zoubeidi

Research Funding - AstraZeneca; Gilead Sciences